feed,title,long_url,short_url
Benzinga,Magenta Therapeutics Reveals Encouraging Interim Data From Lowest Dose Of MGTA-117 In Leukemia Trial,https://benzinga.com/general/biotech/22/05/27225996/magenta-therapeutics-reveals-encouraging-interim-data-from-lowest-dose-of-mgta-117-in-leukemia-tr,https://bit.ly/39kSq0h
Benzinga,"AbbVie, Cugene Ink Licensing Pact For Autoimmune & Inflammatory Disease Candidate",https://benzinga.com/general/biotech/22/05/27223520/abbvie-cugene-ink-licensing-pact-for-autoimmune-inflammatory-disease-candidate,https://bit.ly/3Lkpxib
